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Chronic, pulmonary infections remain the most prominent
cause of the increased morbidity and mortality in CCL with
more than 95% of deaths due to respiratory failure. The bac-
teria most frequently isolated from the sputum of patients with
CCL and pulmonary infection by standard aerobic microbio-
logical methods are Pseudomonas, Staphylococcus aureus,
and Burkholderia cepacia complex.
Recently, it has been shown that there are steep oxygen gra-
dients in the mucus of the patients with CCL leading to prolif-
eration of Pseudomonas within hypoxic media that generates
fully hypoxic (anaerobic) conditions in the lungs of patients
with CCL with persistent respiratory infection [1]. Because of
that there is the real possibility that CCL pulmonary infectionis poly-microbial with anaerobic bacteria that are not detected
by routine aerobic culture methods.
A number of studies have detected pathogenic anaerobic
bacteria in significant numbers in the lungs of patients with
CCL by culture [2].
Mainly Pseudomonas and B. cepacia complex are the
principal anaerobic pathogens in lungs of patients with CCL
such as pneumonia, lung abscesses, and emphysema in which
aerobes and anaerobes were present in a poly-microbial
nfection and were considered to be of significance [3].
The presence of anaerobes in the lungs of patients with
CCL could be important because current antibiotic treatment
targeting aerobic bacteria may be ineffective against anaerobic
bacteria, which may result in a less optimal treatment outcome
for patients [3].
In this study, we used strict anaerobic bacteriologic culture
techniques to detect anaerobic bacteria in sputum and
broncho-alveolar lavage fluid (BAL) to determine the suscepti-
bility of these anaerobes to a range of antibiotics [3].
842 N.A. Moniem, N.M. AminAim of the work
 To determine whether anaerobic bacteria are present in the
sputum of patients with CCL and its role in pathogenesis of
these lesions.
 To detect the antimicrobial susceptibility of anaerobic bac-
terial infection in CCL patients in Beni-Suef University
Hospital.
Patients and methods
There are currently 100 adults attending the chest department
in Beni-Suef University Hospital at the time of this study:
75 patients had chronic Pseudomonas infection.
10 patients had chronic B. cepacia complex infection.
15 infected by a number of different pathogens.
20 healthy volunteers (control).
All were clinically stable patients who were capable of
expectorating sputum sample. Clinical stability was defined
as no change in symptoms, FEV1 within 10% of best value
in the previous 6 months, and no new antibiotic.
Collection of sputum samples from adult patients with CCL
Sputum samples were collected in sterile containers. After
collection, all samples were transferred within 15 min to
an anaerobic cabinet in the microbiology laboratory for
processing.
Collection of BAL from patients with CCL
BAL samples were frozen within 5–10 min of collection and
stored at 70 C. When all samples had been collected, they
were transported in dry ice at 70 C to microbiology depart-
ment for processing. Samples were subsequently thawed in the
anaerobic cabinet at 37 C before processing.Table 1 Bacteria isolated by culture from the sputum of adult pati
Aerobic isolates
Name No of isolates
from 100 sputum samples
% of isolat
100 sputum
1- Pseudomonas aeruginosa 100 100
2- B. cepacia complex 20 20
3- Rothia 3 3
4- Streptococcus 73 73
5- Staphylococcus 31 31
6- Micrococcus 15 15
7- Neisseria 10 10
8- Bacillus 17 17
9- E. coli 8 8
10 Stenotrophomonas 5 5
Total 282 100Results
Tables 1 and 2.
Discussion
This study provides evidence that the lungs of patients with
CCL are not only chronically colonized with pathogens such
as Pseudomonas, but also by a range of other bacterial species,
many of which are anaerobes. A high percentage of the
patients with stable CCL was examined to have numbers of
anaerobes in sputum equal to or greater than those of
Pseudomonas. In a number of samples, more than one
anaerobic species was detected, indicating that the anaerobes
exhibited far greater microbial diversity than previously asso-
ciated with the lung of CCL. Furthermore, we detected similar
anaerobic species in multiple samples collected from the same
patients at different time points, which suggests persistence of
these bacteria within the lung of those patients. These culture
results support the results of many molecular studies, which
indicated the presence of metabolically active bacterial com-
munity within the lung of patients with CCL [4].
The anaerobes detected by culture in the present study and
previously by molecular methods were those that would nor-
mally be found colonizing the oropharynx [5]. It is possible,
therefore, in patients with CCL who have impaired mucocil-
iary clearance mechanisms, that these bacteria are carried from
the oropharynx into the lower airways where they colonize the
lung and potentially contribute to infection and lung damage.
Furthermore, the anaerobes detected were similar to those
found in other studies of anaerobic pulmonary infection, such
as pneumonia, lung abscesses, and emphysema were aerobes
and anaerobes were present in a poly-microbial infection and
were considered to be of significance [3].
Colonization with Pseudomonas significantly increased the
likelihood that anaerobic bacteria would be present in the spu-
tum. This suggests that a preceding bacterial infection, with
Pseudomonas renders airway secretions frankly anaerobic
and creates the environment required for subsequent anaerobic
infection. Consistent with this hypothesis is the observationents with chronic chest lesions.
Anaerobic isolates
es from
samples
Name No % of isolates From
100 Sputum samples
1- prevotella 29 29
2- Actinomyces 10 10
3- Veillonella 7 7
4- Propionibacterium 7 7
5- Peptostreptococcus 1
6- BuHeidia 1
7- Bifidobacterium 1
8- Gemella 1
9- Lactobacillus 1
10- Fusiobacterium 1
11- Clostridium 1
12- Staphylococcus 1
13- Streptococcus 1
Total 62 100
Table 2 Antimicrobial susceptibility of anaerobic bacteria isolated from the sputum of adult patients with chronic chest lesions.
Isolates (62) Ampicillin Clindamycin Meropenem Metronidazole Piperacillin Tazobactam
Name No MIC MIC Sus MIC MIC SUS MIC MIC SUS MIC MIC SUS MIC MIC
50% 90% P. 50% 90% 50% 90% 50% 90% 50% 90%
Prevotella 29 1.05 R 0.19 1.25 R 0.047 0.094 S 0.75 1.62 R 0.125 0.92
Veillonella 7 1.55 R 0.125 0.19 S 0.094 0.19 S 0.21 0.32 S 0.38 1.9
Probionibacterium 7 0.125 S 0.23 0.19 S 0.064 0.25 S 0.19 1.85 R 0.094 0.5
Actinomyces 10 1.5 R 0.19 0.16 S 0.032 0.02 S 0.06 0.71 S 0.038 0.06
Others 9 1.5 R 0.19 1.62 R 0.047 0.125 S 0.71 1.9 R 0.25 0.5
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obic conditions in the lungs of patients with CCL with persis-
tent respiratory infection. Furthermore, Pseudomonas has
been previously shown to rapidly reduce oxygen levels in
media during growth under either batch or continuous culture
conditions [1].
In addition to aerobic bacteria, such as Pseudomonas and
B. cepacia complex, which are assumed to be the key patho-
gens in CCL pulmonary infection, Streptococcus spp. was also
detected in the sputum of patients with CCL. These facultative
aerobes would not be routinely considered as primary patho-
gens in chronic pulmonary infection, with the presence of
Streptococcus spp. in the sputum conventionally believed to
be as a result of oral contamination [6].
However, in the present study, these bacteria were detected
in sputum in numbers equal to Pseudomonas, which suggests
that they may be contributing to infection and lung damage.
This finding is similar to that reported by DuanK and col-
leagues [7] who also performed quantitative microbiology on
CCL sputum samples and found that the concentration of
oropharyngeal strains, such as Streptococcus and Staphylococ-
cus spp., was regularly equal to or higher than that of
Pseudomonas. Interestingly, DuanK and colleagues [7] also
demonstrated that the presence of Streptococcus spp. isolated
from the sputum of patients with CCL enhanced lung damage
caused by Pseudomonas infection [7].
Anaerobic bacteria constitute a major component of the
normal oral flora; concerns have been expressed regarding
contamination of sputum samples by the anaerobic flora
during sampling. Indeed, majority of the anaerobic species
cultured from sputum in this study have been associated with
the oro-pharynx [8].
In this study comparison of the viable count of the anaer-
obes and Pseudomonas isolated from each sample revealed
that, in a high percentage of samples the anaerobe or
anaerobes were present in equal or greater numbers than
Pseudomonas; because it is recognized as a primary pathogen
frequently isolated from sputum, it is extremely unlikely that a
significant number of anaerobic bacteria would be acquired
during expectoration to equal or exceed the number of
Pseudomonas present in the sputum (Table 1).
BAL greatly reduces the risk of oral or upper respiratory
tract contamination associated with sputum sample collection
[9]. Bronchoscopy was performed using a laryngeal mask air-
way to further reduce the risk of contamination. Significantly,
although present in lower numbers in BAL, we cultured similar
anaerobic species in BAL and sputum samples. Given that the
total viable count of aerobes detected in BAL was also less insputum, although only a small number of samples were
processed, anaerobes were detected in the lungs of patients
in the absence of Pseudomonas. This suggests that anaerobes
may cause early infection and then, with time, produce an
environment favorable for subsequent infection with
Pseudomonas (Table 1).
Control persons’ anaerobes were present in lower numbers
and with, different species as compared with CCL and mainly
due to contamination from oral flora. These results taken
together with the culture results from BAL samples, clearly
indicate that the anaerobic bacteria cultured from CCL
sputum samples were derived from the lungs and were not
contaminants derived from the anaerobic oral flora. This con-
firms the results of a recent molecular study that compared the
bacterial communities in the oral cavity and the lungs of
patients with CCL and found that sputum samples were not
contaminated to a significant effect by bacterial species found
within the oral cavity [4,9].
Although lung function was similar in patients from whom
anaerobes were and were not cultured, the presence of anaer-
obes in the lungs of patients with CCL could still be of impor-
tant clinical relevance, both as a pure anaerobic infection and
in co-infection with Pseudomonas. The anaerobic bacteria that
we have detected in the sputum of patients with CCL possess
several virulence factors that may be important in the patho-
genesis of CCL pulmonary infection. These factors include
the following: secretion of a variety of extracellular enzymes,
such as proteases and P-lactamase, which may have a detri-
mental effect on host defense mechanisms and antibiotic
response respectively; capsule production bio-film formation
neutrophil chemotaxis and resistance to phagocytosis.
Furthermore, anaerobes, even when present in low numbers
in mixed infections, such as chronic sinusitis and lung
abscesses, interact synergistically with aerobic or facultative
bacteria and enhance virulence [10].
Moreover, if anaerobic bacteria are contributing to a
poly-microbial infection within the lung of CCL, their presence
may require a change in the antibiotic CCL used for both
treatment of pulmonary exacerbations and for eradication of
initial colonization to ensure optimal outcome for the patient
[11].
In the present study, the use of chronic maintenance
antibiotic therapy had no effect on culture of anaerobic bacte-
ria. This finding was not unexpected given the fact that the
antibiotic CCL used primarily for maintenance therapy—
clindamycin, azithromycin, and tobramycin—has poor activity
against anaerobic bacteria, including those that we have
cultured from CCL sputum (Table 2).
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lates to a range of antibiotic with known activity against
anaerobes. Because gram-positive anaerobic bacteria, such as
Actinomyces and propioni-bacterium species, are commonly
resistant to nitroimidazoles, it was not surprising that a high
percentage of isolates within these species were resistant to
metronidazole. However, the finding that approximately half
of the Prevotella isolates examined were resistant to metron-
idazole was unexpected given that metronidazole resistance
among gram-negative anaerobic bacteria is reported to be
extremely low. Interestingly, all of the anaerobic isolates tested
were susceptible to meropenem, which is used in the treatment
of pulmonary exacerbations caused by Pseudomonas, where it
shows some superiority over other anti-pseudomonal antibi-
otic (Table 2).
These findings clearly demonstrate that antibiotic with
known activity against anaerobic bacteria may not be effective
against anaerobes isolated from CCL sputum and coupled
with the need for better patient outcomes and highlight the
importance of both culturing anaerobes from sputum and
subsequently targeting antibiotic treatment against both anaer-
obes and aerobes colonizing the lungs of patients with CCL [1].
Conclusion
The results of this study show that a range of potentially
pathogenic anaerobic species is present in large numbers of
patients with stable CCL. If these anaerobic bacteria are
contributing significantly to infection and inflammation in
the CCL lung, informed alterations to antibiotic treatment to
target anaerobes, in addition to the primary colonizing patho-
gens, may improve the management of infective exacerbations.
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